Patents-Review.com
ClassID:

97110 ⎘

C07K16/10 - page 2 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus

Recent Application in this class:
#301
20220041694
2022-02-10

SARS-COV-2 ANTIBODIES FOR TREATMENT AND PREVENTION OF COVID-19

 #302
20220033522
2022-02-03

Materials and methods for multidirectional biotransportation in virotherapeutics

 #303
20220025071
2022-01-27

TETRAHEDRAL ANTIBODIES

 #304
20220024990
2022-01-27

SPECIES OF TOBAMOVIRUS

 #305
20220017606
2022-01-20

SARS-COV-2(SARS2, COVID-19) ANTIBODIES

 #306
20220017605
2022-01-20

HUMAN ANTIBODIES TARGETING ZIKA VIRUS NS1, NS1 POLYPEPTIDES AND USES THEREOF

 #307
20220017604
2022-01-20

ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES

 #308
20220017587
2022-01-20

Dual cytokine fusion proteins comprising IL-10

 #309
20220010002
2022-01-13

Compounds specific to coronavirus S protein and uses thereof

 #310
20220001006
2022-01-06

Virus like nanoparticle compositions and methods thereof

 #311
20210403538
2021-12-30

Pan-ebola virus neutralizing human antibodies and methods of use therefor

 #312
20210403537
2021-12-30

Binding agents to pre-fusion state SARS-CoV-2 spike protein

 #313
20210401984
2021-12-30

IMMUNOPROTECTIVE PRIMARY MESENCHYMAL STEM CELLS AND METHODS

 #314
20210395346
2021-12-23

STEREOTYPIC NEUTRALIZING VH CLONOTYPES AGAINST SARS-COV-2 RBD IN COVID-19 PATIENTS AND THE HEALTHY POPULATION

 #315
20210395345
2021-12-23

Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies

 #316
20210395344
2021-12-23

VARIANT NUCLEIC ACID LIBRARIES FOR CORONAVIRUS

 #317
20210388067
2021-12-16

Compounds specific to coronavirus S protein and uses thereof

 #318
20210388066
2021-12-16

Anti-coronavirus antibodies and methods of use

 #319
20210388065
2021-12-16

ANTIBODIES TO SARS-CORONAVIRUS (COVID-19) S1 SPIKE PROTEIN

 #320
20210373020
2021-12-02

Systems and processes to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of 2019 (COVID-19)

 #321
20210373019
2021-12-02

SYSTEMS AND PROCESSES TO SCREEN FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) OF 2019 (COVID-19)

 #322
20210371504
2021-12-02

Antibodies against SARS-CoV-2 and methods of using the same

 #323
20210371503
2021-12-02

NEUTRALIZING ANTIBODIES AGAINST SARS-RELATED CORONAVIRUS

 #324
20210371472
2021-12-02

Influenza virus hemagglutinin mutants

 #325
20210355196
2021-11-18

SARS-COV-2 ANTIBODIES AND METHODS OF SELECTING AND USING THE SAME

 #326
20210355195
2021-11-18

ANTI-CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE

 #327
20210355194
2021-11-18

Variant nucleic acid libraries for coronavirus

 #328
20210355193
2021-11-18

MONOCLONAL ANITBODY FOR SPIKE PROTEIN OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS AND USE THEREOF

 #329
20210347860
2021-11-11

Antibodies for SARS-CoV-2 and uses thereof

 #330
20210347859
2021-11-11

Reduction of viral disease transmission by avian antibodies

 #331
20210347858
2021-11-11

ALIMENTARY AND SYSTEMIC ANTIVIRAL THERAPEUTICS

 #332
20210341478
2021-11-04

RECOMBINANT ANTIBODIES, KITS COMPRISING THE SAME, AND USES THEREOF

 #333
20210340226
2021-11-04

HUMAN MEDICAL PROPHYLAXIS OF CORONAVIRIDAE PATHOGENIC INFECTION BY TOPICAL APPLICATION OF IMMUNE CORONAVIRIDAE IMMUNOGLOBULIN A

 #334
20210340225
2021-11-04

SARS-COV-2 (SARS2, COVID-19) ANTIBODIES

 #335
20210340224
2021-11-04

Bispecific antibody against rabies virus, and application thereof

 #336
20210340189
2021-11-04

SARS-COV-2 N PROTEIN AND METHODS OF USE

 #337
20210340184
2021-11-04

INFLUENZA VIRUS HEMAGGLUTINIIN MUTANTS

 #338
20210332110
2021-10-28

Neutralizing anti-SARS-CoV-2 antibodies and methods of use thereof

 #339
20210324414
2021-10-21

COMPOSITIONS AND METHODS FOR SEQUESTERING VIRUSES

 #340
20210324051
2021-10-21

ANTIBODY-MEDIATED NEUTRALIZATION OF MARBURG VIRUS

 #341
20210324050
2021-10-21

Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses

 #342
20210324049
2021-10-21

ANTIBODIES HAVING SPECIFICITY FOR THE ORF2I PROTEIN OF HEPATITIS E VIRUS AND USES THEREOF FOR DIAGNOSTIC PURPOSES

 #343
20210324048
2021-10-21

Compounds specific to coronavirus S protein and uses thereof

 #344
20210322480
2021-10-21

Platelet-Rich Plasma Compositions and Related Methods

 #345
20210317475
2021-10-14

RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS

 #346
20210317191
2021-10-14

Anti-RSV monoclonal antibody formulation

 #347
20210309973
2021-10-07

Bacteriophage-Based Antibodies and Binders

 #348
20210308254
2021-10-07

Human rotavirus strains and vaccines

 #349
20210302434
2021-09-30

SARS-CoV-2 surrogate virus neutralization assay test kit

 #350
20210300999
2021-09-30

Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

 #351
20210299246
2021-09-30

METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT OF VIRAL OR VIRALLY-INDUCED INFECTIONS AND CONDITIONS, AND ANTI-VIRAL COMPOSITIONS AND THEIR PRODUCTION

 #352
20210292394
2021-09-23

FILOVIRUS ANTIBODY

 #353
20210292393
2021-09-23

Anti-Coronavirus Antibodies and Methods of Use

 #354
20210292392
2021-09-23

Anti-SARS-COV-2 antibodies and uses thereof

 #355
20210277093
2021-09-09

IMMUNOTHERAPEUTIC COMPOSITIONS AND METHODS OF PRODUCTION FOR CORONAVIRUS

 #356
20210277092
2021-09-09

HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)

 #357
20210269510
2021-09-02

ANTIBODIES HAVING SPECIFICITY FOR THE ORF2I PROTEIN OF HEPATITIS E VIRUS AND USES THEREOF FOR DIAGNOSTIC PURPOSES

 #358
20210268404
2021-09-02

Methods for quantitating individual antibodies from a mixture

 #359
20210261650
2021-08-26

Antibodies against SARS-CoV-2 and methods of using the same

 #360
20210260201
2021-08-26

EXTRACELLULAR VESICLES FOR THE TREATMENT AND PREVENTION OF INFECTIONS AND OTHER DISEASES

 #361
20210260116
2021-08-26

Chimeric antigen receptor-modified NK-92 cells

 #362
20210253675
2021-08-19

Anti-yellow fever antibodies, and methods of their generation and use

 #363
20210252146
2021-08-19

STABLE ANTIBODY FORMULATION

 #364
20210246431
2021-08-12

Human Betacoronavirus Lineage C and Identification of N-Terminal Dipeptidyl Peptidase As Its Virus Receptor

 #365
20210238261
2021-08-05

Monoclonal antibody that binds a MERS-coronavirus

 #366
20210221872
2021-07-22

Ebola virus antibodies and binding agents derived therefrom

 #367
20210221853
2021-07-22

Influenza virus hemagglutinin mutants

 #368
20210208160
2021-07-08

Peptides representing epitopes from filoviruses

 #369
20210198323
2021-07-01

RECOMBINANT NEWCASTLE DISEASE VIRUSES AND USES THEREOF FOR THE PREVENTION OF RSV DISEASE OR HUMAN METAPNEUMOVIRUS DISEASE

 #370
20210188948
2021-06-24

Antibodies against dengue virus and related methods

 #371
20210188947
2021-06-24

Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies

 #372
20210179669
2021-06-17

HEPATITIS E VIRUS ORF2 CAPSID POLYPEPTIDES AND USES THEREOF

 #373
20210171611
2021-06-10

ANTIBODY THAT BINDS TO ENVELOPE GLYCOPROTEIN OF SEVER FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS AND USE FOR SAME

 #374
20210147514
2021-05-20

ZIKA NEUTRALIZING ANTIBODY COMPOSITIONS AND METHODS OF USING THE SAME

 #375
20210147513
2021-05-20

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

 #376
20210130441
2021-05-06

Compositions and methods for the treatment of immunodeficiency

 #377
20210130416
2021-05-06

Methods of optimizing nucleotide sequences encoding engineered influenza proteins

 #378
20210095007
2021-04-01

ANTIBODIES THAT BIND EBOLA GLYCOPROTEIN AND USES THEREOF

 #379
20210087258
2021-03-25

Norovirus antibody

 #380
20210079068
2021-03-18

ANTIBODY GENE THERAPY FOR TREATMENT AND PREVENTION OF INFECTION BY RABIES LYSSAVIRUS

 #381
20210079067
2021-03-18

Neutralizing antibodies to ebola virus glycoprotein and their use

 #382
20210061889
2021-03-04

Compositions and methods for inhibiting pathogen infection

 #383
20210047388
2021-02-18

NUCLEIC ACID ANTIBODY CONSTRUCTS FOR USE AGAINST EBOLA VIRUS

 #384
20210040183
2021-02-11

Antibodies that potently neutralize hepatitis B virus and uses thereof

 #385
20210031123
2021-02-04

Methods for quantitating individual antibodies from a mixture

 #386
20210024617
2021-01-28

Human antibodies to Ebola virus glycoprotein

 #387
20210009663
2021-01-14

ANTIBODIES THAT BIND ZIKA VIRUS ENVELOPE PROTEIN AND USES THEREOF

 #388
20210002355
2021-01-07

Compositions and methods for inhibiting pathogen infection

 #389
20200407428
2020-12-31

Therapeutic antibodies to Marburg virus

 #390
20200405844
2020-12-31

Combination HMPV/RSV RNA vaccines

 #391
20200360397
2020-11-19

ANTI-VIRAL COMPOSITIONS CONTAINING PIKFYVE INHIBITORS AND USE THEREOF

 #392
20200354438
2020-11-12

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #393
20200354437
2020-11-12

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #394
20200354436
2020-11-12

Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof

 #395
20200354435
2020-11-12

Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof

 #396
20200339669
2020-10-29

BINDING MOLECULES TARGETING PATHOGENS

 #397
20200339667
2020-10-29

Anti-RSV monoclonal antibody formulation

 #398
20200319181
2020-10-08

ANTIBODY PRODUCING NON-HUMAN ANIMALS

 #399
20200299363
2020-09-24

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #400
20200299362
2020-09-24

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #401
20200299361
2020-09-24

Monoclonal antibodies and cocktails for treatment of Ebola infections

 #402
20200299360
2020-09-24

COMPOSITIONS AND METHODS FOR TREATMENT IN BROAD-SPECTRUM, UNDIFFERENTIATED OR MIXED CLINICAL APPLICATIONS

 #403
20200299359
2020-09-24

DNA antibody constructs for use against middle east respiratory syndrome coronavirus

 #404
20200283507
2020-09-10

Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use

 #405
20200282046
2020-09-10

Betacoronavirus mRNA vaccine

 #406
20200281953
2020-09-10

COMBINATION TUMOR IMMUNOTHERAPY

 #407
20200277358
2020-09-03

ENGINEERED POLYPEPTIDES AND USES THEREOF

 #408
20200268908
2020-08-27

Rabies vaccine

 #409
20200264176
2020-08-20

ANTI-DENGUE VIRUS ANTIBODIES AND USES THEREOF

 #410
20200255500
2020-08-13

Composition and method for activating latent human immunodeficiency virus (HIV)

 #411
20200237913
2020-07-30

Formulations of antibody molecules to dengue virus

 #412
20200231656
2020-07-23

Norovirus antibodies

 #413
20200216519
2020-07-09

DNA-encoded monoclonal antibodies targeting the Ebolavirus glycoprotein

 #414
20200207841
2020-07-02

Full spectrum anti-dengue antibody

 #415
20200200749
2020-06-25

Antibody-mediated neutralization of ebolaviruses

 #416
20200199202
2020-06-25

Methods of treating filovirus infections utilizing bispecific antibodies and fusion proteins that bind EBOV and NPC1

 #417
20200197510
2020-06-25

Betacoronavirus mRNA vaccine

 #418
20200181241
2020-06-11

Ultralong complementarity determining regions and uses thereof

 #419
20200157192
2020-05-21

FC-FUSION PROTEIN DERIVATIVES WITH HIGH DUAL HIV ANTIVIRAL AND IMMUNOMODULATORY ACTIVITY

 #420
20200148751
2020-05-14

Human antibodies to Ebola virus glycoprotein

 #421
20200148750
2020-05-14

Ebola Virus Antibodies and Binding Agents Derived Therefrom

 #422
20200148725
2020-05-14

Norovirus fusion proteins and VLPS comprising norovirus fusion proteins

 #423
20200131251
2020-04-30

IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF

 #424
20200123235
2020-04-23

BIOMIMETIC POLYMERS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES

 #425
20200123233
2020-04-23

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

 #426
20200102576
2020-04-02

Sin Nombre virus full-length M segment-based DNA vaccines

 #427
20200087381
2020-03-19

Antibodies to Andes hantavirus, and methods for using same

 #428
20200069788
2020-03-05

Avian reovirus vaccines

 #429
20200066372
2020-02-27

METHOD FOR IMPROVING ANTIBODY STABILITY

 #430
20200062829
2020-02-27

Antibody capable of binding to norovirus, composite, detection device and method using the same

 #431
20200062828
2020-02-27

Antibody capable of binding to norovirus, composite, detection device and method using the same

 #432
20200054735
2020-02-20

Human rotavirus strains and vaccines

 #433
20200048649
2020-02-13

Virus-like particles and uses thereof

 #434
20200040066
2020-02-06

Antibody-mediated neutralization of Marburg virus

 #435
20200040065
2020-02-06

Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop

 #436
20200025759
2020-01-23

Antibody, composite, detection device and method using same

 #437
20200023076
2020-01-23

RNA encoding an antibody

 #438
20200010810
2020-01-09

Methods and compositions for inducible extracellular membrane capture of monoclonal immunoglobulins secreted by hybridomas

 #439
20200002405
2020-01-02

Arenavirus monoclonal antibodies and uses

 #440
20190374640
2019-12-12

Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins

 #441
20190352342
2019-11-21

Hepatitis E virus ORF2 capsid polypeptides and uses thereof

 #442
20190351049
2019-11-21

Human Antibodies to Middle East Respiratory Syndrome - Coronavirus Spike Protein

 #443
20190336597
2019-11-07

METHODS OF GENERATING ROBUST PASSIVE AND ACTIVE IMMUNE RESPONSES

 #444
20190315838
2019-10-17

Antibodies that bind zika virus envelope protein and uses thereof

 #445
20190314503
2019-10-17

Single domain antibodies directed against arachidonate 12-lipoxygenase

 #446
20190290750
2019-09-26

DNA ANTIBODY CONSTRUCTS FOR USE AGAINST EBOLA VIRUS

 #447
20190282694
2019-09-19

Immunoprotective primary mesenchymal stem cells and methods

 #448
20190270792
2019-09-05

Biological therapeutics for infection-relating disorders or conditions

 #449
20190264226
2019-08-29

Non-integrating viral delivery system and methods related thereto

 #450
20190263894
2019-08-29

MONOCLONAL ANTIBODY COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

 #451
20190256579
2019-08-22

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

 #452
20190255169
2019-08-22

Compositions and methods for treating arenavirus infection

 #453
20190247501
2019-08-15

MONOCLONAL ANTIBODY COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

 #454
20190247493
2019-08-15

CMV vaccines

 #455
20190240317
2019-08-08

HPIV3 RNA vaccines

 #456
20190227077
2019-07-25

Assays for detecting antibodies capable of mediating antibody-dependent cell-mediated cytotoxicity

 #457
20190225674
2019-07-25

TOOLS FOR NEXT GENERATION KOMAGATAELLA (PICHIA) ENGINEERING

 #458
20190216917
2019-07-18

hMPV RNA vaccines

 #459
20190209674
2019-07-11

DNA antibody constructs encoding anti-ZIKV envelope antibodies

 #460
20190194299
2019-06-27

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

 #461
20190185548
2019-06-20

ANTIVIRAL POLYCLONAL ANTIBODIES AGAINST EBOLA VIRUS AND THE USES THEREOF

 #462
20190185547
2019-06-20

Filovirus antibody

 #463
20190184312
2019-06-20

Methods for quantitating individual antibodies from a mixture

 #464
20190144506
2019-05-16

Compositions and methods for preventing and treating Zika virus infection

 #465
20190125853
2019-05-02

Norovirus vaccine formulations

 #466
20190112360
2019-04-18

Antibody that binds to envelope glycoprotein of severe fever with thrombocytopenia syndrome virus and use for same

 #467
20190085058
2019-03-21

DNA antibody constructs and method of using same

 #468
20190077847
2019-03-14

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

 #469
20190071489
2019-03-07

Neutralizing antibodies to Ebola virus glycoprotein and their use

 #470
20190054084
2019-02-21

Combination products for the treatment of RSV

 #471
20190048066
2019-02-14

Human antibodies to Ebola virus glycoprotein

 #472
20190025305
2019-01-24

Compositions and Methods for Evaluating Viral Receptor/Co-Receptor Usage and Inhibitors of Virus Entry Using Recombinant Virus Assays

 #473
20190023769
2019-01-24

Compositions and methods for inhibiting pathogen infection

 #474
20190023745
2019-01-24

METHODS AND COMPOSITIONS FOR ZIKA VIRUS VACCINES

 #475
20190022211
2019-01-24

Rabies virus G protein epitope, and rabies virus neutralising binding molecule that binds specifically thereto

 #476
20190016785
2019-01-17

Antibodies that potently neutralize hepatitis B virus and uses thereof

 #477
20190002535
2019-01-03

Antibody capable of binding to norovirus, composite, detection device and method using the same

 #478
20190002534
2019-01-03

Human antibodies against rabies and uses thereof

 #479
20180371461
2018-12-27

Aptamers, nucleic acid molecules, polynucleotides, synthetic antibodies compositions for detecting PRRS viruses and treating PRRS virus infection

 #480
20180371063
2018-12-27

Therapy and prophylaxis of infectious disease caused by zika virus

 #481
20180362620
2018-12-20

HUMANIZED ANTI-EBOLA VIRUS GLYCOPROTEIN ANTIBODIES AND METHODS OF USE

 #482
20180334494
2018-11-22

Recombinant antibodies that recognize the C-terminal domains of Ebola virus nucleoprotein

 #483
20180328929
2018-11-15

Mutated HEV polypeptides and the use thereof for assaying anti-HEV antibodies

 #484
20180327800
2018-11-15

MONOCLONAL ANTIBODY PRODUCTION BY EBV TRANSFORMATION OF B CELLS

 #485
20180326045
2018-11-15

Combination PIV3/hMPV RNA vaccines

 #486
20180312574
2018-11-01

Antibody-mediated neutralization of Marburg virus

 #487
20180298082
2018-10-18

B cell lineage based immunogen design with humanized animals

 #488
20180291088
2018-10-11

Neutralizing antibodies to Ebola virus glycoprotein and their use

 #489
20180273611
2018-09-27

Method for development of monoclonal antibodies

 #490
20180265550
2018-09-20

THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR FLAVIVIRUSES

 #491
20180258159
2018-09-13

Compositions and methods for the treatment of immunodeficiency

 #492
20180251527
2018-09-06

Single domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use

 #493
20180251526
2018-09-06

Anti-RSV monoclonal antibody formulation

 #494
20180244758
2018-08-30

Monoclonal antibodies and cocktails for treatment of ebola infections

 #495
20180244757
2018-08-30

Monoclonal antibodies specific for heartland virus and methods of their use

 #496
20180244756
2018-08-30

Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

 #497
20180237504
2018-08-23

Full spectrum anti-dengue antibody

 #498
20180237503
2018-08-23

Monoclonal antibody neutralizing infectivity of all ebola viruses

 #499
20180237502
2018-08-23

PAN-EBOLA AND PAN-FILOVIRUS PROTECTIVE EPITOPES, ANTIBODIES, AND ANTIBODY COCKTAILS

 #500
20180236061
2018-08-23

Avian reovirus vaccines

 #501
20180236060
2018-08-23

Human rotavirus vaccine strains and diagnostics

 #502
20180208628
2018-07-26

Species of tobamovirus

 #503
20180207260
2018-07-26

Porcine epidemic diarrhea virus vaccine

 #504
20180185469
2018-07-05

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

 #505
20180180614
2018-06-28

Antibody-mediated neutralization of Ebola viruses

 #506
20180162914
2018-06-14

Methods of optimizing nucleotide sequences encoding engineered influenza proteins

 #507
20180155411
2018-06-07

HETEROTYPIC ANTIBODIES SPECIFIC FOR HUMAN ROTAVIRUS

 #508
20180142004
2018-05-24

Antibody producing non-human animals

 #509
20180142002
2018-05-24

Antibody producing non-human animals

 #510
20180141999
2018-05-24

Bispecific antibodies and fusion proteins that bind to EBOV and NPC1

 #511
20180140699
2018-05-24

Methods for preparing hepatitis B immunoglobulin derived from plasma

 #512
20180134770
2018-05-17

Antibody producing non-human animals

 #513
20180134767
2018-05-17

Identification of antibodies specific for lyssaviruses and methods of their use

 #514
20180133305
2018-05-17

Versatile influenza virus vaccine composition

 #515
20180112247
2018-04-26

RECOMBINANT PRODUCTION OF MIXTURES OF ANTIBODIES

 #516
20180105587
2018-04-19

BINDING MOLECULES TARGETING PATHOGENS

 #517
20180105583
2018-04-19

Antibodies that bind Zika virus envelope protein and uses thereof

 #518
20180105580
2018-04-19

Filovirus therapy

 #519
20180105579
2018-04-19

Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof

 #520
20180094289
2018-04-05

RECOMBINANT PRODUCTION OF MIXTURES OF ANTIBODIES

 #521
20180086818
2018-03-29

Compositions and methods for the treatment of immunodeficiency

 #522
20180080042
2018-03-22

Whole expressed cell as antigen carrier, and use thereof in preparing vaccine or diagnostic agent, and screening monoclonal antibodies

 #523
20180071389
2018-03-15

Monoclonal Antibodies for Ebola and Marburg Viruses

 #524
20180066279
2018-03-08

RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS

 #525
20180037634
2018-02-08

Engineered polypeptides and uses thereof

 #526
20180031555
2018-02-01

Antibody producing non-human animals

 #527
20180030118
2018-02-01

HUMANZIED FILOVIRUS ANTIBODIES AND USES THEREOF

 #528
20180028540
2018-02-01

Anti-viral compositions containing PIKfyve inhibitors and use thereof

 #529
20180022790
2018-01-25

EQUINE IMMUNOGLOBULIN COMPOSITIONS AND USES FOR TREATING FILOVIRUS-MEDIATED DISEASES

 #530
20180016322
2018-01-18

Antibodies specific to glycoprotein (GP) of and uses for the treatment and diagnosis of ebola virus infection

 #531
20180002721
2018-01-04

Stable production of lentiviral vectors

 #532
20180002675
2018-01-04

Human ebola virus species and compositions and methods thereof

 #533
20180002405
2018-01-04

METHOD FOR SELECTING A SINGLE CELL EXPRESSING A HETEROGENEOUS COMBINATION OF ANTIBODIES

 #534
20180002404
2018-01-04

Method for selecting a single cell expressing a heterogeneous combination of antibodies

 #535
20180000851
2018-01-04

Combination tumor immunotherapy

 #536
20170355751
2017-12-14

Human antibodies to Ebola virus glycoprotein

 #537
20170342387
2017-11-30

Pestivirus

 #538
20170340732
2017-11-30

Polymeric IgA-type recombinant antibody and use thereof

 #539
20170340728
2017-11-30

Human antibodies to Middle East Respiratory Syndrome—coronavirus spike protein

 #540
20170334973
2017-11-23

Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins

 #541
20170327564
2017-11-16

Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications

 #542
20170313765
2017-11-02

DIRECT EXPRESSION OF ANTIBODIES

 #543
20170313763
2017-11-02

Compositions and methods related to viral vaccines

 #544
20170304566
2017-10-26

Methods of treating RSV infections

 #545
20170304565
2017-10-26

Inhalation device for use in aerosol therapy of respiratory diseases

 #546
20170304431
2017-10-26

Vaccine for use in protecting a pig against porcine epidemic diarrhea virus

 #547
20170304363
2017-10-26

COMPOSITIONS AND METHODS FOR TREATING VIRAL HEMORRHAGIC FEVER

 #548
20170298120
2017-10-19

Antibodies that bind Ebola glycoprotein and uses thereof

 #549
20170298119
2017-10-19

ANTIBODY MOLECULES TO ZIKA VIRUS AND USES THEREOF

 #550
20170274076
2017-09-28

FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS

 #551
20170258899
2017-09-14

Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same

 #552
20170253647
2017-09-07

BIOMIMETIC POLYMERS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES

 #553
20170252425
2017-09-07

ZIKA VIRUS VIRUS LIKE PARTICLE

 #554
20170247434
2017-08-31

Norovirus antibodies

 #555
20170246209
2017-08-31

TREATING VIRAL HEMORRHAGIC FEVER WITH NK-92 CELLS

 #556
20170240616
2017-08-24

Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity

 #557
20170233460
2017-08-17

Anti-dengue virus NS1 protein monoclonal antibodies

 #558
20170233459
2017-08-17

Systems and methods for the production of human polyclonal antibodies

 #559
20170226192
2017-08-10

METHODS OF MODULATING AN IMMUNE RESPONSE

 #560
20170218052
2017-08-03

CROSS-REACTIVE ANTIBODIES AGAINST DENGUE VIRUS AND USES THEREOF

 #561
20170204166
2017-07-20

Therapy for filovirus infection

 #562
20170196964
2017-07-13

Arenavirus vaccine

 #563
20170183396
2017-06-29

EBOLA MONOCLONAL ANTIBODIES

 #564
20170182163
2017-06-29

Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins

 #565
20170166925
2017-06-15

Recombinant AAV vectors useful for reducing immunity against transgene products

 #566
20170158753
2017-06-08

MONOCLONAL ANTIBODIES DIRECTED AGAINST ENVELOPE GLYCOPROTEINS FROM MULTIPLE FILOVIRUS SPECIES

 #567
20170158752
2017-06-08

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

 #568
20170121392
2017-05-04

Single domain antibodies directed against ebola virus VP24

 #569
20170121391
2017-05-04

POTENT GLYCOPROTEIN ANTIBODY AS A THERAPEUTIC AGAINST EBOLA VIRUS

 #570
20170096455
2017-04-06

Methods and compositions for chimeric coronavirus spike proteins

 #571
20170088873
2017-03-30

Feeding strategies and purification processes for monoclonal antibody production

 #572
20170088606
2017-03-30

Therapy for filovirus infection

 #573
20170080078
2017-03-23

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

 #574
20170066815
2017-03-09

Monoclonal antibodies that neutralize a norovirus

 #575
20170065702
2017-03-09

METHODS OF MODULATING AN IMMUNE RESPONSE

 #576
20170028055
2017-02-02

Avian reovirus vaccines

 #577
20160346376
2016-12-01

Sin Nombre virus full-length M segment-based DNA vaccines

 #578
20160333365
2016-11-17

Method of purifying monoclonal antibodies

 #579
20160326234
2016-11-10

MONOCLONAL ANTIBODY COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

 #580
20160326233
2016-11-10

Neutralizing human monoclonal antibodies against hepatitis B virus surface antigen

 #581
20160319320
2016-11-03

Recombinant production of mixtures of antibodies

 #582
20160311891
2016-10-27

DNA antibody constructs and method of using same

 #583
20160296619
2016-10-13

CMV vaccines

 #584
20160296617
2016-10-13

Immunogenic composition for MERS coronavirus infection

 #585
20160275238
2016-09-22

Method for improving antibody stability

 #586
20160272696
2016-09-22

Production of recombinant proteins with simple glycoforms

 #587
20160264647
2016-09-15

Human monoclonal antibodies against the middle east respiratory syndrome coronavirus (MERS-CoV) and engineered bispecific fusions with inhibitory peptides

 #588
20160238600
2016-08-18

Antibody producing non-human animals

 #589
20160235837
2016-08-18

THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR MIDDLE EAST RESPIRATORY SYNDROME VIRUS (MERS CoV)

 #590
20160215040
2016-07-28

Human antibodies to ebola virus glycoprotein

 #591
20160209411
2016-07-21

Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays

 #592
20160206729
2016-07-21

Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methods

 #593
20160194383
2016-07-07

Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use

 #594
20160166711
2016-06-16

Rabies vaccine

 #595
20160152693
2016-06-02

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

 #596
20160151492
2016-06-02

Monoclonal antibodies for Ebola and Marburg viruses

 #597
20160137722
2016-05-19

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

 #598
20160129110
2016-05-12

Immunoprotective primary mesenchymal stem cells and methods

 #599
20160115221
2016-04-28

Compositions and methods for the treatment of immunodeficiency

 #600
20160114037
2016-04-28

Compositions and methods for the treatment of immunodeficiency